Prostate cancer management—helping your patient choose what is best for him
| Autor: | A. van der Merwe, C.F. Heyns |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Oncology
medicine.medical_specialty Prostatectomy business.industry medicine.medical_treatment Public Health Environmental and Occupational Health Cancer medicine.disease Metastasis Androgen deprivation therapy Prostate cancer Prostate-specific antigen Internal medicine medicine Family Practice business Watchful waiting Cancer staging |
| Zdroj: | South African Family Practice. 50:27-34 |
| ISSN: | 2078-6204 2078-6190 |
| Popis: | The biggest problems in prostate cancer management are how to identify patients with potentially life-threatening cancer, and how to choose the best form of management from among the large array of treatment options. Although prostate cancer in the second or third most common cause of cancer death in males, most men with this diagnosis will die of other causes.The most important prognostic factors are the patient's life expectancy, the grade and stage of the tumour and the serum prostate specific antigen (PSA) at diagnosis. The most important management options are (1) active surveillance (watchful waiting), (2) androgen deprivation therapy (ADT), (3) radical prostatectomy and (4) radiotherapy.Patients with a limited life expectancy or non-aggressive cancer can be managed with active surveillance and be treated only if and when it becomes necessary. ADT (hormone therapy) provides excellent palliation in men with locally advanced or metastatic cancer, but the side-effects decrease quality of life.R... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|